TNF and Dupuytren Contracture: While TNF has been identified as a potential therapeutic target in Dupuytren’s disease (24), information on the response of Dupuytren’s cells and tissues to TNF-α in terms of collagen protein synthesis and production of normal versus abnormal type I collagen is currently lacking.